HEADER APOPTOSIS 20-DEC-18 6QB4 TITLE MCL1-SCFV COMPLEX WITH AN INDOLE ACID INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL- COMPND 3 1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: BCL-2-LIKE PROTEIN 3,BCL2-L-3,BCL-2-RELATED PROTEIN COMPND 6 EAT/MCL1,MCL1/EAT; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: SCFV55; COMPND 10 CHAIN: X; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MCL1, BCL2L3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_TAXID: 9606; SOURCE 11 EXPRESSION_SYSTEM: CRICETULUS GRISEUS; SOURCE 12 EXPRESSION_SYSTEM_TAXID: 10029 KEYWDS MCL1, SCFV, INDOLE ACID, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR D.HARGREAVES REVDAT 2 13-NOV-19 6QB4 1 JRNL REVDAT 1 06-NOV-19 6QB4 0 JRNL AUTH J.LUPTAK,M.BISTA,D.FISHER,L.FLAVELL,N.GAO,K.WICKSON, JRNL AUTH 2 S.L.KAZMIRSKI,T.HOWARD,P.B.RAWLINS,D.HARGREAVES JRNL TITL ANTIBODY FRAGMENTS STRUCTURALLY ENABLE A DRUG-DISCOVERY JRNL TITL 2 CAMPAIGN ON THE CANCER TARGET MCL-1. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 75 1003 2019 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 31692474 JRNL DOI 10.1107/S2059798319014116 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.11 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 16880 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.197 REMARK 3 FREE R VALUE : 0.231 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.110 REMARK 3 FREE R VALUE TEST SET COUNT : 863 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 43 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.40 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.23 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 393 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2432 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 372 REMARK 3 BIN R VALUE (WORKING SET) : 0.2390 REMARK 3 BIN FREE R VALUE : 0.3178 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.34 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2871 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 34 REMARK 3 SOLVENT ATOMS : 157 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.27 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.34890 REMARK 3 B22 (A**2) : 0.09540 REMARK 3 B33 (A**2) : -1.44430 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.98050 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.399 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.235 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.383 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.235 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.924 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2968 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4022 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1015 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 502 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2968 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 379 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3101 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.72 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.08 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6QB4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 20-DEC-18. REMARK 100 THE DEPOSITION ID IS D_1200013553. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.92 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16889 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 42.150 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.51 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.49 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PCPT 0.1M PH 7.5, PEG 3350 15%W/V, REMARK 280 MGCL2 0.1M, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 72.47350 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 20.43050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 72.47350 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 20.43050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1440 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, X REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 166 REMARK 465 PRO A 167 REMARK 465 LEU A 168 REMARK 465 GLY A 169 REMARK 465 SER A 170 REMARK 465 GLU A 171 REMARK 465 SER A 196 REMARK 465 LYS A 197 REMARK 465 PRO A 198 REMARK 465 LEU A 199 REMARK 465 GLY A 200 REMARK 465 GLU A 201 REMARK 465 ALA A 202 REMARK 465 GLY A 203 REMARK 465 GLU A 322 REMARK 465 ASP A 323 REMARK 465 LEU A 324 REMARK 465 GLU A 325 REMARK 465 GLY A 326 REMARK 465 GLY A 327 REMARK 465 SER X 119 REMARK 465 GLY X 120 REMARK 465 GLY X 121 REMARK 465 GLY X 122 REMARK 465 GLY X 123 REMARK 465 SER X 124 REMARK 465 GLY X 125 REMARK 465 GLY X 126 REMARK 465 GLY X 127 REMARK 465 GLY X 128 REMARK 465 SER X 129 REMARK 465 GLY X 130 REMARK 465 GLY X 131 REMARK 465 GLY X 132 REMARK 465 GLY X 133 REMARK 465 SER X 134 REMARK 465 ALA X 135 REMARK 465 ALA X 249 REMARK 465 GLU X 250 REMARK 465 ASN X 251 REMARK 465 LEU X 252 REMARK 465 TYR X 253 REMARK 465 PHE X 254 REMARK 465 GLN X 255 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN X 163 -95.60 -103.01 REMARK 500 ASN X 187 -47.29 78.60 REMARK 500 ASN X 188 14.11 -146.63 REMARK 500 ALA X 220 -174.85 -170.75 REMARK 500 ALA X 247 -143.58 -120.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HVN A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6QB3 RELATED DB: PDB REMARK 900 CONTAINS THE SAME COMPLEX BUT APO DBREF 6QB4 A 174 327 UNP Q07820 MCL1_HUMAN 174 327 DBREF 6QB4 X 1 255 PDB 6QB4 6QB4 1 255 SEQADV 6QB4 GLY A 166 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 PRO A 167 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 LEU A 168 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 GLY A 169 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 SER A 170 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 GLU A 171 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 ASP A 172 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 ASP A 173 UNP Q07820 EXPRESSION TAG SEQADV 6QB4 SER A 193 UNP Q07820 ALA 193 CONFLICT SEQADV 6QB4 SER A 196 UNP Q07820 THR 196 CONFLICT SEQADV 6QB4 LEU A 199 UNP Q07820 MET 199 CONFLICT SEQADV 6QB4 GLU A 201 UNP Q07820 ARG 201 CONFLICT SEQADV 6QB4 ALA A 202 UNP Q07820 SER 202 CONFLICT SEQADV 6QB4 ALA A 205 UNP Q07820 THR 205 CONFLICT SEQADV 6QB4 GLY A 206 UNP Q07820 SER 206 CONFLICT SEQADV 6QB4 ARG A 208 UNP Q07820 LYS 208 CONFLICT SEQRES 1 A 162 GLY PRO LEU GLY SER GLU ASP ASP LEU TYR ARG GLN SER SEQRES 2 A 162 LEU GLU ILE ILE SER ARG TYR LEU ARG GLU GLN ALA THR SEQRES 3 A 162 GLY SER LYS ASP SER LYS PRO LEU GLY GLU ALA GLY ALA SEQRES 4 A 162 ALA GLY ARG ARG ALA LEU GLU THR LEU ARG ARG VAL GLY SEQRES 5 A 162 ASP GLY VAL GLN ARG ASN HIS GLU THR ALA PHE GLN GLY SEQRES 6 A 162 MET LEU ARG LYS LEU ASP ILE LYS ASN GLU ASP ASP VAL SEQRES 7 A 162 LYS SER LEU SER ARG VAL MET ILE HIS VAL PHE SER ASP SEQRES 8 A 162 GLY VAL THR ASN TRP GLY ARG ILE VAL THR LEU ILE SER SEQRES 9 A 162 PHE GLY ALA PHE VAL ALA LYS HIS LEU LYS THR ILE ASN SEQRES 10 A 162 GLN GLU SER CYS ILE GLU PRO LEU ALA GLU SER ILE THR SEQRES 11 A 162 ASP VAL LEU VAL ARG THR LYS ARG ASP TRP LEU VAL LYS SEQRES 12 A 162 GLN ARG GLY TRP ASP GLY PHE VAL GLU PHE PHE HIS VAL SEQRES 13 A 162 GLU ASP LEU GLU GLY GLY SEQRES 1 X 255 GLN VAL THR LEU LYS GLU SER GLY GLY GLY LEU VAL LYS SEQRES 2 X 255 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 X 255 PHE THR PHE SER SER TYR SER MET ASN TRP VAL ARG GLN SEQRES 4 X 255 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER SER ILE SER SEQRES 5 X 255 SER SER SER SER TYR ILE TYR TYR ALA ASP SER VAL LYS SEQRES 6 X 255 GLY ARG PHE THR ILE SER ARG ASP ASN ALA LYS ASN SER SEQRES 7 X 255 LEU TYR LEU GLN MET ASN SER LEU ARG ALA GLU ASP THR SEQRES 8 X 255 ALA VAL TYR TYR CYS ALA ARG GLN VAL GLY ALA THR TRP SEQRES 9 X 255 ALA PHE ASP ILE TRP GLY GLN GLY THR LEU VAL THR VAL SEQRES 10 X 255 SER SER GLY GLY GLY GLY SER GLY GLY GLY GLY SER GLY SEQRES 11 X 255 GLY GLY GLY SER ALA GLN SER VAL LEU THR GLN PRO PRO SEQRES 12 X 255 SER ALA SER GLY THR PRO GLY GLN ARG VAL THR ILE SER SEQRES 13 X 255 CYS SER GLY SER SER SER ASN ILE GLY SER ASN THR VAL SEQRES 14 X 255 ASN TRP TYR GLN GLN LEU PRO GLY THR ALA PRO LYS LEU SEQRES 15 X 255 LEU ILE TYR SER ASN ASN GLN ARG PRO SER GLY VAL PRO SEQRES 16 X 255 ASP ARG PHE SER GLY SER LYS SER GLY THR SER ALA SER SEQRES 17 X 255 LEU ALA ILE SER GLY LEU GLN SER GLU ASP GLU ALA ASP SEQRES 18 X 255 TYR TYR CYS ALA ALA TRP ASP ASP SER LEU ASN ALA TRP SEQRES 19 X 255 VAL PHE GLY GLY GLY THR LYS LEU THR VAL LEU GLY ALA SEQRES 20 X 255 ALA ALA GLU ASN LEU TYR PHE GLN HET HVN A 401 34 HETNAM HVN 3-[3-[[(1~{R})-1,2,3,4-TETRAHYDRONAPHTHALEN-1- HETNAM 2 HVN YL]OXY]PROPYL]-7-(1,3,5-TRIMETHYLPYRAZOL-4-YL)-1~{H}- HETNAM 3 HVN INDOLE-2-CARBOXYLIC ACID FORMUL 3 HVN C28 H31 N3 O3 FORMUL 4 HOH *157(H2 O) HELIX 1 AA1 ASP A 172 GLY A 192 1 21 HELIX 2 AA2 ALA A 205 HIS A 224 1 20 HELIX 3 AA3 HIS A 224 ASP A 236 1 13 HELIX 4 AA4 ASN A 239 SER A 255 1 17 HELIX 5 AA5 ASN A 260 ILE A 281 1 22 HELIX 6 AA6 GLN A 283 SER A 285 5 3 HELIX 7 AA7 CYS A 286 GLN A 309 1 24 HELIX 8 AA8 ARG A 310 PHE A 319 1 10 HELIX 9 AA9 THR X 28 TYR X 32 5 5 HELIX 10 AB1 ASP X 62 LYS X 65 5 4 HELIX 11 AB2 ASN X 74 LYS X 76 5 3 HELIX 12 AB3 ARG X 87 THR X 91 5 5 HELIX 13 AB4 GLN X 215 GLU X 219 5 5 SHEET 1 AA1 4 THR X 3 SER X 7 0 SHEET 2 AA1 4 LEU X 18 SER X 25 -1 O SER X 21 N SER X 7 SHEET 3 AA1 4 SER X 78 MET X 83 -1 O MET X 83 N LEU X 18 SHEET 4 AA1 4 PHE X 68 ASP X 73 -1 N SER X 71 O TYR X 80 SHEET 1 AA2 6 LEU X 11 VAL X 12 0 SHEET 2 AA2 6 THR X 113 VAL X 117 1 O THR X 116 N VAL X 12 SHEET 3 AA2 6 ALA X 92 GLN X 99 -1 N ALA X 92 O VAL X 115 SHEET 4 AA2 6 SER X 33 GLN X 39 -1 N VAL X 37 O TYR X 95 SHEET 5 AA2 6 LEU X 45 ILE X 51 -1 O GLU X 46 N ARG X 38 SHEET 6 AA2 6 ILE X 58 TYR X 60 -1 O TYR X 59 N SER X 50 SHEET 1 AA3 4 LEU X 11 VAL X 12 0 SHEET 2 AA3 4 THR X 113 VAL X 117 1 O THR X 116 N VAL X 12 SHEET 3 AA3 4 ALA X 92 GLN X 99 -1 N ALA X 92 O VAL X 115 SHEET 4 AA3 4 PHE X 106 TRP X 109 -1 O ILE X 108 N ARG X 98 SHEET 1 AA4 5 SER X 144 GLY X 147 0 SHEET 2 AA4 5 THR X 240 VAL X 244 1 O THR X 243 N ALA X 145 SHEET 3 AA4 5 ALA X 220 ASP X 228 -1 N ALA X 220 O LEU X 242 SHEET 4 AA4 5 ASN X 170 GLN X 174 -1 N ASN X 170 O ALA X 225 SHEET 5 AA4 5 LYS X 181 ILE X 184 -1 O ILE X 184 N TRP X 171 SHEET 1 AA5 4 SER X 144 GLY X 147 0 SHEET 2 AA5 4 THR X 240 VAL X 244 1 O THR X 243 N ALA X 145 SHEET 3 AA5 4 ALA X 220 ASP X 228 -1 N ALA X 220 O LEU X 242 SHEET 4 AA5 4 ALA X 233 PHE X 236 -1 O VAL X 235 N ALA X 226 SHEET 1 AA6 3 ARG X 152 SER X 158 0 SHEET 2 AA6 3 SER X 206 SER X 212 -1 O LEU X 209 N ILE X 155 SHEET 3 AA6 3 PHE X 198 SER X 203 -1 N SER X 199 O ALA X 210 SSBOND 1 CYS X 22 CYS X 96 1555 1555 2.04 SSBOND 2 CYS X 157 CYS X 224 1555 1555 2.05 SITE 1 AC1 8 HIS A 224 MET A 250 VAL A 253 ARG A 263 SITE 2 AC1 8 LEU A 267 PHE A 270 SER X 216 GLU X 217 CRYST1 144.947 40.861 77.354 90.00 111.42 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006899 0.000000 0.002706 0.00000 SCALE2 0.000000 0.024473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013887 0.00000